In the current study, to characterize the mechanism by which CDK8/19 contributes to the proliferation of prostate cancer cells, we primarily utilized prostate cancer VCaP cells, which displayed the highest sensitivity to CDK8/19 inhibition among the prostate cancer cells tested. The gene discussed is CDK8; the disease is prostate carcinoma.